Toshiyuki Kozuki

机构：Kōchi University · ORCID：0000-0001-8432-8975

发表论文 245 篇 · 总被引 6558 次 · h-index 34

代表论文

• Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study (2024 · Journal of Clinical Oncology · 被引 226)
• Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer (2024 · Journal of Clinical Oncology · 被引 158)
• A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6–Targeting Antibody–Drug Conjugate, in Patients with Small Cell Lung Cancer (2024 · Clinical Cancer Research · 被引 35)
• Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC (2025 · Nature Communications · 被引 17)
• Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib (2024 · Journal of Thoracic Oncology · 被引 11)
• Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer (2025 · Asia-Pacific Journal of Clinical Oncology · 被引 1)